NVST Add to watchlist $23.55 0.12 (-0.51%) Last updated: May 31, 2026 03:49
52-Week Range
$23.55
$17.78 $23.55 $30.42

Fundamentals Overview

Envista Holdings Corp is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 57.9 PEG 0.55 P/B 1.25 P/S 1.36

Intrinsic value (DCF)

+113.1% upside vs price

Profitability

Net margin 2.4%

Risk (Beta)

0.93 — in line vol

Earnings & growth

EPS $0.41 Rev -6% Profit +17.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 61% confidence Risk: Moderate Volatility — Beta 0.93. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +113.1% upside vs price · Analyst grade: B+ · Sentiment improving (2 upgrades)

Pressures (Sell):

3M vs S&P 500: -29.5% · 3M vs Healthcare sector: -15.1%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$3.83B
P/E (TTM)
57.88
EPS (TTM)
$0.41
Dividend Yield
N/A
52-Week Range
$17.78 - $30.42
Volume vs Avg
N/A
Beta
0.93

About

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies seg...
Sector: Healthcare
Headquarters: US
Employees: 12,300
IPO Date: Sep 2019
Beta: 0.93 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 4, Equal Weight: 4, Hold: 1, Neutral: 14, Outperform: 5, Overweight: 1, Underperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $50.18; current price is $23.55. That’s a +113.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 57.88
DCF value (model) $50.18 (113.1% upside)
PEG (TTM) 0.55
P/B (TTM) 1.25
P/S (TTM) 1.36
P/FCF (TTM) 17.4
Liquidity & enterprise
Current Ratio (TTM) 2.44
Quick Ratio (TTM) 2.06
Cash Ratio (TTM) 1.38
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 2.41%
Gross margin (TTM) 55.14%
Operating margin (TTM) 9.04%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for NVST.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 4Equal Weight 4Hold 1Neutral 14Outperform 5Overweight 1Underperform 1
2 upgrades, 0 downgrades
Price Target Consensus
Current $23.55
Median $25.00
Consensus $27.44
Low consensus $19.00
High consensus $35.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
JP Morgan maintain Neutral Neutral 2026-05-07
Evercore ISI Group maintain Outperform Outperform 2026-05-07
Baird maintain Outperform Outperform 2026-05-07
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-24
Evercore ISI Group maintain Outperform Outperform 2026-04-08
Barclays maintain Overweight Overweight 2026-02-11
Mizuho maintain Neutral Neutral 2026-02-10
Stifel maintain Buy Buy 2026-02-06
JP Morgan maintain Neutral Neutral 2026-02-06
Piper Sandler maintain Neutral Neutral 2026-02-06
Wells Fargo maintain Equal Weight Equal Weight 2026-02-06
Stifel maintain Buy Buy 2026-02-04
UBS maintain Neutral Neutral 2026-02-03
Piper Sandler maintain Neutral Neutral 2026-01-30
Mizuho upgrade Underperform Neutral 2026-01-20
JP Morgan maintain Neutral Neutral 2025-12-16
Mizuho maintain Underperform Underperform 2025-08-01
Morgan Stanley maintain Equal Weight Equal Weight 2025-08-01
Piper Sandler maintain Neutral Neutral 2025-08-01
Wells Fargo maintain Equal Weight Equal Weight 2025-08-01
Stifel maintain Buy Buy 2025-08-01
UBS maintain Neutral Neutral 2025-07-29
Evercore ISI Group maintain Outperform Outperform 2025-07-09
Baird upgrade Neutral Outperform 2025-05-27
UBS maintain Neutral Neutral 2025-05-05
Baird maintain Neutral Neutral 2025-05-02
Piper Sandler maintain Neutral Neutral 2025-04-30
B of A Securities maintain Buy Buy 2025-04-29
UBS maintain Neutral Neutral 2025-03-10
Needham maintain Hold Hold 2025-03-06